Drug guidance
Echinocandins for treating invasive candidiasis
Condition
Infections
8 February 2023
Published on 08 Feb 2023
Last Updated on 08 Feb 2023
Guidance Recommendations
The Ministry of Health's Drug Advisory Committee has recommended:
Anidulafungin 100 mg injection
in line with its registered indications for treating invasive candidiasis in view of favourable clinical and cost-effectiveness compared with other echinocandins.
Funding status
Anidulafungin 100 mg injection is recommended for inclusion on the MOH Standard Drug List (SDL) from 1 April 2023.
Subsidy does not apply to micafungin 50 mg injection or caspofungin 50 mg and 70 mg injections.